Evaluation of Optical Genome Mapping in Phi Negative Myeloproliferative Neoplasia in the Detection of Acquired Cytogenetic Abnormalities

Conditions:   Myeloproliferative Neoplasm;   Optical Genome Mapping;   Cytogenetics;   Clonality;   Prognostic Stratification Intervention:   Other: Blood sample Sponsors:   Centre Hospitalier Universitaire, Amiens;   Hôpital Jeanne de Flandre LIlle;   Centre Henri Becquerel Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials